From professional translators, enterprises, web pages and freely available translation repositories.
imest
stemi
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
no imest
non stemi
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
no se vio ninguna diferencia significativa en la población con imest.
no significant difference was seen in the stemi population.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
los pacientes presentaban sca con ai de moderado a alto riesgo, imsest o imest y tratados con icp.
patients had acs with moderate to high risk ua, nstemi, or stemi and were managed with pci.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
muerte cv im no-mortal ictus no-mortal imest eventos de la variable combinada primaria
cv death, nonfatal mi, or nonfatal stroke cv death nonfatal mi nonfatal stroke stemi primary composite outcome events
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
en el grupo con imest estos procedimientos se realizaron en el 44%, 27% y 4% respectivamente.
en el grupo con imest estos procedimientos se realizaron en el 44%, 27% y 4% respectivamente.
Last Update: 2018-02-13
Usage Frequency: 1
Quality:
los pacientes con ai/imsest con síntomas durante 72 horas o con imest con síntomas entre 12 horas y 14 días se aleatorizaron después de conocer la anatomía coronaria.
patients with ua/nstemi within 72 hours of symptoms or stemi between 12 hours to 14 days of symptoms were randomised after knowledge of coronary anatomy.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
efient, co-administrado con ácido acetilsalicílico (aas), está indicado para la prevención de eventos aterotrombóticos en pacientes adultos con síndrome coronario agudo (p.ej. angina inestable, infarto de miocardio sin elevación del segmento st [ai/imsest] o infarto de miocardio con elevación del segmento st [imest]) sometidos a intervención coronaria percutánea (icp) primaria o aplazada.
efient, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndrome (i.e. unstable angina, non-st segment elevation myocardial infarction [ua/nstemi] or st segment elevation myocardial infarction [stemi]) undergoing primary or delayed percutaneous coronary intervention (pci).
Last Update: 2017-04-26
Usage Frequency: 1
Quality: